The aim of Australia’s Security Sensitive Biological Agents (SSBAs) Regulatory Scheme is to limit opportunities for acts of bioterrorism or criminal acts using harmful biological agents. The scheme is based on a two-tiered list of agents, of which many can cause disease in animals and thereby have the potential to significantly impact Australian agricultural industries and the economy. Laboratories handling these agents have clear responsibilities for their biocontainment, biosafety and biosecurity. Importantly, through research and ongoing improvements to diagnostic assays and techniques, these facilities also play an integral role in threat preparedness, mitigation, diagnosis and control of natural, accidental or deliberate outbreaks of disease.

澳大利亚的“安全敏感生物制剂”（SSBA）监管计划的目的是限制使用有害生物制剂进行生物恐怖主义行为或犯罪行为的机会。该计划基于两级代理，其中许多代理可以导致动物疾病，因此有可能对澳大利亚农业和经济产生重大影响。处理这些药物的实验室对其生物防护，生物安全和生物安全负有明确的责任。重要的是，通过对诊断测定方法和技术的研究和不断改进，这些设施在威胁准备，缓解，诊断和控制自然，偶然或故意疾病暴发方面也起着不可或缺的作用。